Journal profile · RESPIRATORY SYSTEM
Chronic Respiratory Disease
ISSN 1479-9723 · eISSN 1479-9731 · SAGE Publications Ltd · ENGLAND
Chronic Respiratory Disease: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.66; fully open access; APC about USD 2,650; review about 11 weeks (community reports); acceptance rate 22.8% (journal website); 50 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Chronic Respiratory Disease is published by SAGE Publications Ltd and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory Support and Mechanisms and Asthma and respiratory diseases, together about 51.3% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Chronic Respiratory Disease is a peer-reviewed, open access, scholarly journal, created in response to the rising incidence of chronic respiratory diseases worldwide. View full journal description This journal is a member of the Committee on Publication Ethics (COPE).
From the journal's Aims & Scope
Research area (LetPub): RESPIRATORY SYSTEM
Editor-in-chief Neil J. GreeningPublisher website
Editorial board by country: none in mainland China; most named United Kingdom 20, Canada 6, Australia 6, United States 2, Netherlands 1 (41 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine29.7%
- Respiratory Support and MechanismsMedicine14.6%
- Asthma and respiratory diseasesMedicine7%
- Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine5%
- Cystic Fibrosis Research AdvancesMedicine4.2%
- Cardiovascular and exercise physiologyMedicine3.9%
- Delphi Technique in ResearchSocial Sciences3.8%
- Respiratory and Cough-Related ResearchMedicine3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Respiratory System | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Respiratory System | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Respiratory System | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.66LetPub ·
- Impact factor (publisher)
- 2.9Publisher website ·
- 5-year impact factor (publisher)
- 3.2Publisher website ·
- CiteScore 2026-06
- 4.4LetPub ·
- SJR 2026-06
- 0.81LetPub ·
- SNIP 2026-06
- 0.89LetPub ·
- h-index
- 34LetPub ·
- h-index
- 67OpenAlex ·
- i10-index
- 506OpenAlex ·
- 2-year mean citedness
- 3.22OpenAlex ·
- Self-citation rate
- 3.4%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 48LetPub ·
- Articles per year (publisher)
- 3Publisher website ·
Articles by year OpenAlex count · 1,006 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 40 | 40 | 11 |
| 2025 | 50 | 50 | 143 |
| 2024 | 45 | 45 | 281 |
| 2023 | 45 | 45 | 416 |
| 2022 | 52 | 52 | 564 |
| 2021 | 57 | 57 | 1,286 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 11 weeksLetPub ·
- Acceptance rate (publisher)
- 22.8%Publisher website ·
- Submission to first decision
- 8 daysPublisher website ·
- Acceptance to publication
- 25 daysPublisher website ·
- Submission to publication (journal-reported)
- about 11 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,650 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,650 | — | — | |
| Publisher website | USD 3,200 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare8 items from the author guidelines
- Abstract
- ≤ 200 words
- Reference style
- Vancouver
- Templates
- LaTeX and Word
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required
- Highlights
- Required
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted17, with length limits
- case reportView our Special Collections currently accepting submissions. Manuscripts are considered for publication with the understanding that they have not been publishe…main text ≤ 1,200 words
- case reportsCase Reports, up to 1200 words plus referencesLength not stated
- correspondenceView our Special Collections currently accepting submissions. Manuscripts are considered for publication with the understanding that they have not been publishe…Length not stated
- editorialView our Special Collections currently accepting submissions. Manuscripts are considered for publication with the understanding that they have not been publishe…main text ≤ 1,200 words
- editorialsEditorials, up to 1200 words plus referencesLength not stated
- hot topicHot topic, up to 1000 words plus referencesLength not stated
- letterView our Special Collections currently accepting submissions. Manuscripts are considered for publication with the understanding that they have not been publishe…main text ≤ 1,000 words
- lettersLetters, including Research Letters, up to 1000 words plus 2-3 references and 2-3 illustrations or tables.Length not stated
- original paperView our Special Collections currently accepting submissions. Manuscripts are considered for publication with the understanding that they have not been publishe…Length not stated
- original research paperView our Special Collections currently accepting submissions. Manuscripts are considered for publication with the understanding that they have not been publishe…main text ≤ 3,000 words
- original research papersOriginal research papers, 3000 words plus references, with up to six tables or figuresLength not stated
- reviewView our Special Collections currently accepting submissions. Manuscripts are considered for publication with the understanding that they have not been publishe…main text ≤ 1,000 words
- review articleView our Special Collections currently accepting submissions. Manuscripts are considered for publication with the understanding that they have not been publishe…main text ≤ 4,000 words
- review articlesReview articles, 4000 words plus referencesLength not stated
- review of the guidelinesReview of the guidelines, 500-1000 words plus referencesLength not stated
- technical noteView our Special Collections currently accepting submissions. Manuscripts are considered for publication with the understanding that they have not been publishe…main text ≤ 1,000 words
- technical notesTechnical notes, 500-1000 words plus referencesLength not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, Publication ethics, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- Authorship Authorship
Please view our authorship policies, which includes information on criteria for authorship, who should be the corresponding author and more. Please note that AI chatbots, for example ChatGPT, should not be listed as authors. For more information see the policy on Use of ChatGPT and generative AI tools.
Source ↗Publisher website ·- Data availability Data availability
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…
Source ↗Publisher website ·- Publication ethics Ethical considerations
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…
Source ↗Publisher website ·- Open access Publishing fees and open access
Chronic Respiratory Disease is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing, paid by t…
Source ↗Publisher website ·- Peer review Peer review policy
Identity transparency: Double anonymized Model summary
The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…
Source ↗Publisher website ·- Plagiarism Plagiarism
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
Source ↗Publisher website ·- Preprints Preprints
The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical trial registration
The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- SAGE Publications Ltd
- Country or region
- ENGLAND
- Language
- English
- ISSN
- 1479-9723
- Electronic ISSN
- 1479-9731
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Chronic Respiratory Disease
What CAS zone is Chronic Respiratory Disease in?
In the 2025 upgraded edition of the CAS Journal Ranking, Chronic Respiratory Disease is in Zone 3 of Medicine, and in Zone 4 of the minor category Respiratory System. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Chronic Respiratory Disease?
The latest impact factor listed by LetPub is 2.66; CiteScore 4.4, h-index 67.
How long does peer review take at Chronic Respiratory Disease?
Authors report an average review time of about 11 weeks; the journal's website gives an acceptance rate of 22.8%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Chronic Respiratory Disease?
According to the journal's author guidelines: Abstract: ≤ 200 words; Reference style: Vancouver; Templates: LaTeX and Word; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required; Highlights: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Chronic Respiratory Disease based?
Of the 41 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (20), Canada (6) and Australia (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Chronic Respiratory Disease?
According to LetPub and DOAJ records, Chronic Respiratory Disease is indexed in SCIE, Scopus and DOAJ.
Is Chronic Respiratory Disease open access, and what is the APC?
Chronic Respiratory Disease is a fully open-access journal. APC about USD 2,650.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .